News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Early data promising for AstraZeneca cancer drug combination

Started by riky, September 28, 2014, 09:00:47 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Early data promising for AstraZeneca cancer drug combination

<p><a href="http://news.yahoo.com/early-data-promising-astrazeneca-cancer-drug-combination-105005678--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/6tZv1KioFzhQ6Um5EMukJw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9Njk7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-09-27T105005Z_1_LYNXNPEA8Q04T_RTROPTP_2_ASTRAZENECA-PFIZER.JPG" width="130" height="86" alt="A man walks past a sign at an AstraZeneca site in Macclesfield" align="left" title="A man walks past a sign at an AstraZeneca site in Macclesfield" border="0" /></a>By Ben Hirschler MADRID (Reuters) - Early results for a closely watched cancer drug combination from AstraZeneca that boosts the immune system show the cocktail is promising, though limited patient numbers mean the data is far from conclusive. The British drugmaker, which fended off a $118 billion (72.64 billion pound) takeover bid from Pfizer in May in part by talking up its cancer drug prospects, has high hopes for the combination of two experimental drugs known as MEDI4736 and tremelimumab. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login